kringle-pharmaCo., Ltd.

NEWS

notice

Apr 07, 2020 Notice

Kringle Pharma additionally raises 740 million Japanese yen toward commercialization of recombinant human HGF drug.

Kringle Pharma additionally raises 740 million Japanese yen toward commercialization of recombinant human HGF drug.